Research ArticleOriginal Research

Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis

Jeffrey J Swigris, Diane L Fairclough, Marianne Morrison, Barry Make, Elizabeth Kozora, Kevin K Brown and Frederick S Wamboldt
Respiratory Care June 2011, 56 (6) 783-789; DOI: https://doi.org/10.4187/respcare.00939

References

  1. 1.↵
    American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161(2 Pt 1):646–664.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Olson AL,
    2. Swigris JJ,
    3. Lezotte DC,
    4. Norris JM,
    5. Wilson CG,
    6. Brown KK
    . Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007;176(3):277–284.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Nishiyama O,
    2. Taniguchi H,
    3. Kondoh Y,
    4. Kimura T,
    5. Kato K,
    6. Ogawa T,
    7. et al
    . Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD. Respir Med 2007;101(4):833–838.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.
    1. Nishiyama O,
    2. Taniguchi H,
    3. Kondoh Y,
    4. Kimura T,
    5. Ogawa T,
    6. Watanabe F,
    7. et al
    . Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?  Respir Med 2005;99:408–414.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Swigris JJ,
    2. Kuschner WG,
    3. Jacobs SS,
    4. Wilson SR,
    5. Gould MK
    . Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005;60(7):588–594.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Swigris JJ,
    2. Stewart AL,
    3. Gould MK,
    4. Wilson SR
    . Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005;3:61.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Swigris JJ,
    2. Brown KK,
    3. Make BJ,
    4. Wamboldt FS
    . Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med 2008;102(12):1675–1680.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Nici L,
    2. Donner C,
    3. Wouters E,
    4. Zuwallack R,
    5. Ambrosino N,
    6. Bourbeau J,
    7. et al
    . American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173(12):1390–1413.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Bianchi R,
    2. Gigliotti F,
    3. Romagnoli I,
    4. Lanini B,
    5. Castellani C,
    6. Grazzini M,
    7. et al
    . Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest 2004;125(2):459–465.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Bernard S,
    2. Whittom F,
    3. Leblanc P,
    4. Jobin J,
    5. Belleau R,
    6. Berube C,
    7. et al
    . Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159(3):896–901.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Mador MJ,
    2. Kufel TJ,
    3. Pineda LA,
    4. Steinwald A,
    5. Aggarwal A,
    6. Upadhyay AM,
    7. et al
    . Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise. Am J Respir Crit Care Med 2001;163(4):930–935.
    OpenUrlPubMedWeb of Science
  12. 12.↵
    1. Ferreira A,
    2. Garvey C,
    3. Connors GL,
    4. Hilling L,
    5. Rigler J,
    6. Farrell S,
    7. et al
    . Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009;135(2):442–447.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Holland AE,
    2. Hill CJ,
    3. Conron M,
    4. Munro P,
    5. McDonald CF
    . Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008;63(6):549–554.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Nishiyama O,
    2. Kondoh Y,
    3. Kimura T,
    4. Kato K,
    5. Kataoka K,
    6. Ogawa T,
    7. et al
    . Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008;13(3):394–399.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Kozora E,
    2. Emery CF,
    3. Ellison MC,
    4. Wamboldt FS,
    5. Diaz PT,
    6. Make B
    . Improved neurobehavioral functioning in emphysema patients following lung volume reduction surgery compared with medical therapy. Chest 2005;128(4):2653–2663.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Fishman A,
    2. Martinez F,
    3. Naunheim K,
    4. Piantadosi S,
    5. Wise R,
    6. Ries A,
    7. et al
    ; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348(21):2059–2073.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Swigris JJ,
    2. Swick J,
    3. Wamboldt FS,
    4. Sprunger D,
    5. du Bois R,
    6. Fischer A,
    7. et al
    . Heart rate recovery after 6-minute walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009;136(3):841–848.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB
    . Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179–187.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Crapo RO,
    2. Morris AH
    . Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981;123(2):185–189.
    OpenUrlPubMedWeb of Science
  20. 20.↵
    1. Krupp LB,
    2. LaRocca NG,
    3. Muir-Nash J,
    4. Steinberg AD
    . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46(10):1121–1123.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Spitzer RL,
    2. Kroenke K,
    3. Williams JB,
    4. Lowe B
    . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092–1097.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Kroenke K,
    2. Strine TW,
    3. Spitzer RL,
    4. Williams JB,
    5. Berry JT,
    6. Mokdad AH
    . The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009;114(1-3):163–173.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Buysse DJ,
    2. Reynolds CF 3rd.,
    3. Monk TH,
    4. Berman SR,
    5. Kupfer DJ
    . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28(2):193–213.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Mermigkis C,
    2. Stagaki E,
    3. Amfilochiou A,
    4. Polychronopoulos V,
    5. Korkonikitas P,
    6. Mermigkis D,
    7. et al
    . Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. Med Princ Pract 2009;18(1):10–15.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Holland AE,
    2. Hill CJ,
    3. Conron M,
    4. Munro P,
    5. McDonald CF
    . Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir Med 2009;103(10):1430–1435.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Swigris JJ,
    2. Wamboldt FS,
    3. Behr J,
    4. du Bois RM,
    5. King TE,
    6. Raghu G,
    7. et al
    . The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax 2010;65(2):173–177.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Agarwal S,
    2. Richardson B,
    3. Krishnan V,
    4. Schneider H,
    5. Collop NA,
    6. Danoff SK
    . Interstitial lung disease and sleep: what is known? Sleep Med 2009;10(9):947–951.
    OpenUrlPubMed
  28. 28.↵
    1. Krishnan V,
    2. McCormack MC,
    3. Mathai SC,
    4. Agarwal S,
    5. Richardson B,
    6. Horton MR,
    7. et al
    . Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest 2008;134(4):693–698.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Swigris JJ,
    2. Gould MK,
    3. Wilson SR
    . Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 2005;127(1):284–294.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Salhi B,
    2. Troosters T,
    3. Behaegel M,
    4. Joos G,
    5. Derom E
    . Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest 2010;137(2):273–279.
    OpenUrlCrossRefPubMed
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords